Long-term safety of botulinum toxin type A

Movement Disorders

Volumn 18, Issue 9, 2003, Pages 1080-1081

  Naumann, Markus ^a   Moore, A Peter ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BOTULINUM TOXIN A; PLACEBO;

BLEPHAROSPASM; CEREBRAL PALSY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPHONIA; DYSTONIA; ESOPHAGUS ACHALASIA; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; LETTER; LONG TERM CARE; MEIGE DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SPASTICITY;

BOTULINUM TOXIN TYPE A; CLINICAL TRIALS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0141502254     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10495     Document Type: Letter

References (13)

1. Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. New York: Lippincott Williams & Wilkins; 2002.
2. Moore AP, Naumann M. Handbook of botulinum toxin treatment. Oxford: Blackwell Publishing; 2003.
3. Naumann M, Lowe N. A randomized, placebo-controlled, double-blind study of botulinum toxin type A in bilateral axillary hyperhidrosis. Br Med J 2001;323:596-599.
4. Misra VP. The changed image of botulinum toxin. BMJ 2002;325:1188.
5. Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002;59:418-420.
6. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 1999;53:2102-2107.
7. Hsiung G-Y, Das SK, Ranawaya R, Lafontaine AL, Sucherowsky O. Long-term efficacy of botulinurn toxin A in the treatment of various disorders over a 10 year period. Mov Disord 2002;17:1288-1293.
8. Mehta RP, Goldman SN, Orloff LA. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes. Arch Otolaryngol Head Neck Surg 2001;127:393-399.
9. D'Onofrio V, Miletto P, Leandro G, Iaquinto G. Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 2002;34:105-110.
10. Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol 2001; 145:289-293.
11. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol (in press).
12. Borodic GE, Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 1992;12:121-127.
13. de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 1999;96: 3200-3205.